Comparing cardiovascular treatment outcomes across wealthy countries
Comparing approval, adoption/de-adoption and outcomes for advanced cardiovascular procedures across high-income countries
This study looks at how new heart treatments are approved and used in wealthy countries, aiming to find out why patients in the US often have worse heart health outcomes despite spending more on healthcare, so that we can improve treatment and policies for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11041134 on NIH RePORTER |
What this research studies
This research investigates how advanced cardiovascular procedures are approved and adopted in high-income countries, focusing on the differences in outcomes for patients. By analyzing health technology assessments (HTA) and their impact on the use of new treatments, the study aims to understand why the US has poorer cardiovascular outcomes despite higher healthcare spending. Patients may benefit from insights that could lead to improved treatment protocols and better healthcare policies. The research will involve collaboration with international health systems to gather and compare data.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with cardiovascular conditions such as abdominal aortic aneurysms, acute myocardial infarctions, and those requiring advanced cardiovascular procedures.
Not a fit: Patients with non-cardiovascular conditions or those not undergoing advanced cardiovascular procedures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cardiovascular treatment strategies and policies that enhance patient outcomes.
How similar studies have performed: Previous research has shown that health technology assessments can significantly impact treatment adoption and patient outcomes, indicating a promising approach for this study.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Landon, Bruce E. — Harvard Medical School
- Study coordinator: Landon, Bruce E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.